Skip to main content

Publications

Dataroom

Triage of human papillomavirus infected women by methylation analysis in first void urine

Posted on 12/07/2021

Van Keer et al, 2021

Clinical and analytical evaluation of the RealTime High Risk HPV assay in Colli-Pee collected first-void urine using the VALHUDES protocol

Posted on 8/07/2021

Van Keer et al., 2021

Disclaimer

Effective December 8th, 2024, DNA Genotek™ will be the Legal Manufacturer of the Colli-Pee™ product family.
This transfer of all Colli-Pee™ devices to DNA Genotek™ as the new Legal Manufacturer will have no impact to product performance or how you place orders for the product. Please note that this change will have no impact on the Colli-Pee™ device design or specifications and there is no change to Colli-Pee™ device fit, form or function.

The Legal Manufacturing change will only result in changes to Colli-Pee™ device labelling to list DNA Genotek™ as the Legal Manufacturer. For a limited period of time, you may receive product with labelling indicating either Novosanis™ or DNA Genotek™ as the Legal Manufacturer on the product label. Both Novosanis™ and DNA Genotek™ are subsidiaries of OraSure Technologies, Inc.